A comprehensive view of Phase 3 Trial. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Sanofi to conduct Phase 3 clinical trial to evaluate subcutaneous vs intravenous administration of Isatuximab with Pomalidomide and Dexamethasone in adults with relapsed or refractory multiple myeloma; recruitment has not yet started
Published: June 22, 2022 by Immunotherapy Daily
Gsk Announces Positive Phase Iii Data For Rsv Vaccine Candidate For Older Adults
Published: June 10, 2022 by CE Noticias Financieras (Latin America)
Gerresheimer signs agreement with drug development firm ISR for large-scale production of IcoOne nasal inhaler for ISR’s Phase 3 study of its dry powder COVID-19 vaccine; Gerresheimer has annual production capacity of more than 100 million inhalers
Published: June 02, 2022 by Gerresheimer AG
Pfizer partners with Northern Light Health in Brewer, Maine, to conduct third phase of Lyme disease vaccine clinical trial involving about 100 people, with registration starting in July; Maine has highest rate of Lyme disease infections in US
Published: June 02, 2022 by Associated Press
Janssen to conduct Phase 3 trial to study injectable Lazertinib with subcutaneous amivantamab to treat egfr-mutated advanced, metastatic non-small cell lung cancer; drug to be administered after patient progresses on Osimertinib, chemotherapy
Published: June 01, 2022 by Contify Life Science News

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count